Michael W. Bonney, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), bought 2,000 shares at $58.36 ($117K) on 2016-03-09, disclosed to the SEC on 2016-03-10.
Open-market purchase of $117k ALNY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ALNY | SELL | 2023-12-29 | $5.8M | — | Filing → |
| ALNY | SELL | 2023-08-04 | $2.2M | — | Filing → |
| BMY | BUY | 2020-06-09 | $5K | — | Filing → |